Chong Kun Dang Holdings Corp. (KRX:001630)
South Korea
· Delayed Price · Currency is KRW 51,700
+100 (0.19%)
Last updated: Jun 27, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Medicine | 846.81B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medicine Growth | -5.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -31.58B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | -37.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 64.55B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 3.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -31.58B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | -37.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 64.55B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 3.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Consolidated Adjustment | -24.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | -36.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 34.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -0.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 724.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -4.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 76.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | -21.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 56.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 50.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Middle East | 12.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Middle East Growth | 89.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -24.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | -36.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 34.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -0.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|